1. Home
  2. LEXX vs GFAI Comparison

LEXX vs GFAI Comparison

Compare LEXX & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.70

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.65

Market Cap

19.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
GFAI
Founded
2004
2018
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.3M
19.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEXX
GFAI
Price
$0.70
$0.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$1.50
$4.50
AVG Volume (30 Days)
1.5M
335.2K
Earning Date
01-13-2026
09-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
$36,987,715.00
Revenue This Year
$13.35
$5.66
Revenue Next Year
$78.83
$4.69
P/E Ratio
N/A
N/A
Revenue Growth
52.05
4.38
52 Week Low
$0.46
$0.54
52 Week High
$2.43
$3.88

Technical Indicators

Market Signals
Indicator
LEXX
GFAI
Relative Strength Index (RSI) 43.39 41.50
Support Level $0.46 $0.62
Resistance Level $0.72 $0.80
Average True Range (ATR) 0.10 0.05
MACD 0.01 -0.00
Stochastic Oscillator 58.20 40.38

Price Performance

Historical Comparison
LEXX
GFAI

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: